###begin article-title 0
###xml 53 62 <span type="species:ncbi:7955">Zebrafish</span>
Identification of Genetic and Chemical Modulators of Zebrafish Mechanosensory Hair Cell Death
###end article-title 0
###begin p 1
Conceived and designed the experiments: KO FS JS ER DR. Performed the experiments: KO FS BR TL AK AC. Analyzed the data: KO FS BR AC ER DR. Contributed reagents/materials/analysis tools: JS. Wrote the paper: KO FS ER DR.
###end p 1
###begin p 2
###xml 872 880 872 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 882 885 882 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl</italic>
###xml 1145 1153 1145 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 142 148 <span type="species:ncbi:9606">people</span>
###xml 540 549 <span type="species:ncbi:7955">zebrafish</span>
###xml 1086 1095 <span type="species:ncbi:7955">zebrafish</span>
Inner ear sensory hair cell death is observed in the majority of hearing and balance disorders, affecting the health of more than 600 million people worldwide. While normal aging is the single greatest contributor, exposure to environmental toxins and therapeutic drugs such as aminoglycoside antibiotics and antineoplastic agents are significant contributors. Genetic variation contributes markedly to differences in normal disease progression during aging and in susceptibility to ototoxic agents. Using the lateral line system of larval zebrafish, we developed an in vivo drug toxicity interaction screen to uncover genetic modulators of antibiotic-induced hair cell death and to identify compounds that confer protection. We have identified 5 mutations that modulate aminoglycoside susceptibility. Further characterization and identification of one protective mutant, sentinel (snl), revealed a novel conserved vertebrate gene. A similar screen identified a new class of drug-like small molecules, benzothiophene carboxamides, that prevent aminoglycoside-induced hair cell death in zebrafish and in mammals. Testing for interaction with the sentinel mutation suggests that the gene and compounds may operate in different pathways. The combination of chemical screening with traditional genetic approaches is a new strategy for identifying drugs and drug targets to attenuate hearing and balance disorders.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 152 158 <span type="species:ncbi:9606">people</span>
###xml 537 546 <span type="species:ncbi:7955">zebrafish</span>
Loss of sensory hair cells in the inner ear is observed in the majority of hearing and balance disorders, affecting the health of more than 600 million people worldwide. Exposure to environmental toxins and certain pharmaceutical drugs such as aminoglycoside antibiotics and some cancer chemotherapy agents account for many of these hearing and balance problems. Variation in the genetic makeup between individuals plays a major role in establishing differences in susceptibility to environmental agents that damage the inner ear. Using zebrafish larvae, we developed a screen to uncover genes leading to differences in antibiotic-induced death of hair cells and to identify compounds that protect hair cells from damage. The combination of chemical screening with traditional genetic approaches offers a new strategy for identifying drugs and drug targets to attenuate hearing and balance disorders.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 443 446 443 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Gates1">[1]</xref>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Sill1">[5]</xref>
###xml 554 557 554 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Friedman1">[6]</xref>
###xml 751 754 751 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Inoue1">[7]</xref>
###xml 755 758 755 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-McGuirt1">[9]</xref>
###xml 213 219 <span type="species:ncbi:9606">humans</span>
Hearing loss and vestibular dysfunction are among the most common disorders requiring medical attention. Globally, over a third of older adults suffer from these conditions. Studies of both laboratory animals and humans reveal tremendous variation in hearing loss due to ageing as well as exogenous challenges such as ototoxic drugs and noise exposure, and show that this variability can be at least partially understood using genetic methods [1]-[5]. Rapid progress has been made using genetics to understand the molecular basis for congenital deafness [6], but adult-onset hearing loss is poorly understood despite its overwhelming prevalence. There are several examples where genes underlying familial adult-onset hearing loss have been identified [7]-[9], but these are rare diseases that account for a very small fraction of the enormous variation of acquired or age-related hearing and balance problems. Understanding how hair cell death is genetically modified by intrinsic and extrinsic challenges should lead to identification of new therapeutic targets for prevention of inner ear damage.
###end p 6
###begin p 7
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Forge1">[10]</xref>
###xml 439 443 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Nakashima1">[12]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Versnel1">[13]</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Prezant1">[14]</xref>
###xml 916 920 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Guan1">[15]</xref>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Guan2">[16]</xref>
###xml 546 552 <span type="species:ncbi:9606">humans</span>
###xml 666 674 <span type="species:ncbi:9606">patients</span>
The initial cellular basis for most hearing loss and a significant proportion of balance problems is injury and loss of the mechanosensory hair cells that reside in the inner ear and transduce mechanical signals into electrical signals that are sent to the brain via the VIIIth cranial nerve. Treatments with aminoglycoside antibiotics or the cancer chemotherapeutics, cisplatin and carboplatin, often cause irreversible hearing loss [10]-[12] by killing hair cells. As with other forms of hearing loss, the effects of aminoglycoside exposure in humans and other outbred mammalian populations are widely variable and influenced by genetic factors [13]. For example, patients with mutations in mitochondrial genes, including mitochondrial 12S ribosomal RNA, show greatly enhanced sensitivity to aminoglycoside exposure [14]. However, these mutations also have variable penetrance, and are influenced by nuclear genes [15]. Mutations in mitochondrial rRNA are consistent with a model that aminoglycoside ototoxicity is the result of effects on mitochondrial translation similar to the antibiotic effects of prokaryotic translation inhibition [16].
###end p 7
###begin p 8
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Rybak1">[11]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Cheng1">[17]</xref>
Pharmacological approaches toward the prevention of hearing loss due to therapeutic drugs or chronic exposure to noise have centered primarily on antioxidants and cJUN kinase (JunK) inhibitors. While several studies support the idea that antioxidants or JunK inhibitors can limit aminoglycoside toxicity and cisplatin ototoxicity, the literature is complex and often the protection is dose dependent [11],[17]. Target based drug discovery is limited, however, by our understanding of the cellular pathways contributing to the inner ear pathology, and by the lack of methods to do broad screening of potential candidates.
###end p 8
###begin p 9
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-DamblyChaudiere1">[18]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Nicolson1">[19]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Whitfield1">[20]</xref>
###xml 630 634 630 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Harris1">[21]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Ou1">[25]</xref>
###xml 948 952 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Ton1">[26]</xref>
###xml 297 306 <span type="species:ncbi:7955">Zebrafish</span>
###xml 517 526 <span type="species:ncbi:7955">zebrafish</span>
The lateral line system of aquatic vertebrates is composed of mechanosensory organs on the surface of the head and body, and is used to detect variations in water pressure. Lateral line hair cells and their underlying support cells are organized into rosette-like clusters called neuromasts [18]. Zebrafish lateral line hair cells show structural, functional and molecular similarities to the mammalian inner ear hair cells (reviewed in [19],[20]). Like mammalian inner ear hair cells, the lateral line hair cells of zebrafish are killed by exposure to chemicals including aminoglycosides and cisplatin in a dose-dependent manner [21]-[25]. The accessibility of lateral line hair cells to visualization and manipulation, along with the cellular and molecular properties shared with inner ear hair cells, makes this system a good model for investigating genetic and pharmacological modulation of hair cell sensitivity to potentially ototoxic agents [26].
###end p 9
###begin p 10
###xml 569 576 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 397 406 <span type="species:ncbi:7955">zebrafish</span>
In this report, we describe a new approach for the identification of genes and pharmacological agents that modulate the sensitivity of hair cells to ototoxic agents such as aminoglycosides. We use this approach to identify 2 new pharmacological agents and 5 new mutations that protect against aminoglycoside-induced hair cell death. We describe a screen for small drug-like molecules that protect zebrafish lateral line hair cells and validate effectiveness of these newly discovered protective compounds in the mammalian inner ear. We report the initial results of an in vivo genetic screen for modulators of hair cell susceptibility to ototoxic drug exposure, including the identification of one such gene. These mutations provide an entry point for determining which molecular pathways can be modulated to alter drug response in the hair cells. Variation in these molecules may underlie differential susceptibility to drugs clinically and suggest likely points of regulation for prophylactic treatments in the future.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 182 191 182 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1A</xref>
###xml 275 284 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1B</xref>
###xml 510 519 506 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1C</xref>
###xml 668 672 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Harris1">[21]</xref>
###xml 673 677 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Santos1">[23]</xref>
###xml 908 917 904 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1C</xref>
###xml 52 61 <span type="species:ncbi:7955">zebrafish</span>
Hair cells of the lateral line neuromasts in larval zebrafish form an easily identifiable rosette-like cluster that can be labeled with a variety of vital dyes and assessed in vivo (Figure 1A). The hair cells rapidly fragment and die upon treatment with 200 microM neomycin (Figure 1B). We have developed methods to systematically identify modulatory pathways altering hair cell response to aminoglycoside antibiotic exposure by taking advantage of in vivo labeling of lateral line hair cells with vital dyes. Figure 1C exemplifies this, showing that lateral line hair cells have a robust, highly reproducible response to different doses of aminoglycoside antibiotics [21],[23]. We reasoned that by examining animals treated with concentrations of neomycin at low or high ends of the dose-response curve, we should be able to identify modifiers that alter susceptibility to neomycin-induced hair cell death (Figure 1C).
###end p 12
###begin title 13
Screening for modifiers of aminoglycoside toxicity.
###end title 13
###begin p 14
###xml 581 590 <span type="species:ncbi:7955">zebrafish</span>
(A) Neuromast from a control animal pretreated with 0.5% DMSO and stained with rapidly with FM 1-43FX (red) and the nuclear label Yo-Pro-1 (green). (B) Negative control pretreated with 0.05% DMSO for 1 hour followed by 200 microM neomycin treatment for 30 min. Hair cells are stained with FM 1-43FX (red) and Yo-Pro-1 (green). Hair cell loss, nuclear condensation and cytoplasmic shrinking are observed. (C) Dose-response function showing decreased hair cell labeling with DASPEI, a mitochondrial potentiometric dye, as a function of increasing neomycin concentration for wildtype zebrafish (N = 25-37 total fish per group, from triplicate experiments). Bars are SEM. Screens for increased or decreased susceptibility to hair cell loss were performed by treatment with either low, 25 microM, or high, 200 microM, neomycin doses, respectively, as highlighted by the orange arrows. (D) Neuromast pretreated with PROTO-2, a compound identified to provide protection against 200 microM neomycin exposure. (E,F) Show the structure for the identified compounds, PROTO-1 (E) and PROTO-2 (F), respectively.
###end p 14
###begin title 15
Small Molecule Screening for Protecting Compounds
###end title 15
###begin p 16
###xml 750 759 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1D</xref>
###xml 804 813 796 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1B</xref>
###xml 865 881 857 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g001">Figure 1E and 1F</xref>
###xml 1102 1110 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g002">Figure 2</xref>
###xml 1113 1129 1105 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g002">Figure 2A and 2B</xref>
###xml 1452 1468 1428 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g002">Figure 2C and 2D</xref>
To screen for small molecule modifiers, we pretreated 5 day post-fertilization (dpf) larvae with a chemically diverse library of 10,960 compounds before exposing them to 200 microM neomycin. Screening was initially carried out by labeling hair cells of 5 dpf larvae with a combination of a nuclear dye and a cytoplasmic dye (Yo-Pro-1 and FM 1-43, respectively), then pretreating larvae in 96-well tissue culture plates for 1 hour to a cocktail of five compounds and then exposing them to 200 microM neomycin. When protection was observed, the 5 potential contributors were evaluated singly to determine the active compound. Two compounds exhibited reliable and robust protection of hair cells from neomycin. An example of this protection is shown in Figure 1D, compared to treatment with neomycin alone (Figure 1B). Both compounds were benzothiophene carboxamides (Figure 1E and 1F), suggesting specific selection from the diverse library. We have named these compounds PROTO-1 and PROTO-2. We next compared the neomycin dose-response relationship in larvae pretreated with the compounds and controls (Figure 2). Figure 2A and 2B show that at a concentration of 10 microM both compounds show significant protection of hair cells over a broad range of neomycin concentrations, from 25 microM to 400 microM (p<0.0001 by two-factorial ANOVA). We also determined the dose-dependent effects of PROTO-1 and PROTO-2 to a fixed (200 microM) level of neomycin (Figure 2C and 2D). Pretreatment with 1 and 10 microM PROTO-1 resulted in significant protection of hair cells exposed to 200 microM neomycin compared to neomycin alone (p<0.0001, unpaired t-test). There was no significant difference in the protection provided by 1 and 10 microM PROTO-1 (p>0.10). Although exposure to 50 microM and 100 microM PROTO-1 alone did not alter viability, in combination with 200 microM neomycin these doses were lethal to larvae. Pretreatment with PROTO-2 provided significant protection of hair cells at all doses (p<0.0001, unpaired t-tests) with no dose-dependent difference (p>0.20). PROTO-2 was not lethal at any of the tested doses with or without neomycin.
###end p 16
###begin title 17
Ranges of protection for PROTO-1 and PROTO-2.
###end title 17
###begin p 18
Hair cells were vitally stained with FM1-43 and Yo-Pro-1, treated with PROTO-1 or PROT0-2 for 1 hour at various concentrations of compounds, then exposed to neomycin for 30 minutes, allowed 1 hr recovery in normal media. Graphs show mean hair cell counts for the SO1, SO2, OC1, and O1 neuromasts (+SEM) as percent of control (mock-treated, no neomycin exposure). Missing error bars indicate that was less than symbol size. (A,B) Neomycin dose-response curve showing effects of 10 microM PROTO-1 ((A), closed squares) and PROTO-2 ((B), closed squares) pretreatment in comparison to controls (without PROTO-1 or -2). (C,D) Profile of each compound at increasing doses without aminoglycoside and after 200 microM neomycin exposure. N = 10-20 fish per group.
###end p 18
###begin p 19
###xml 526 530 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coli</italic>
###xml 523 530 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Aminoglycosides are used clinically, despite their known ototoxicity, because of their broad spectrum of antibacterial actions. Compounds that could be used to limit their ototoxicity must not limit the intended therapeutic functions. We therefore had the University of Washington Clinical Microbiology Laboratory test the bacteriostatic and bactericidal activity of neomycin in the presence of PROTO-1 and PROTO-2. The minimum inhibitory concentration (3.25 microM) and minimum bactericidal concentration (6.5 microM) for E. coli ATCC 25922 was unchanged with or without 10 microM of either compound. This indicates that at least under standard in vitro assay conditions benzothiophene carboxamides do not inhibit aminoglycoside antibacterial activity.
###end p 19
###begin title 20
Screening for Genetic Modifiers
###end title 20
###begin p 21
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-SolnicaKrezel1">[27]</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mitfa</italic>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Lister1">[28]</xref>
###xml 832 836 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Balak1">[29]</xref>
###xml 837 841 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-BereiterHahn1">[30]</xref>
###xml 843 851 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g003">Figure 3</xref>
###xml 989 998 981 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g003">Figure 3B</xref>
###xml 1001 1011 993 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">persephone</italic>
###xml 1021 1030 1013 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g003">Figure 3C</xref>
###xml 1097 1106 1089 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g003">Figure 3A</xref>
###xml 1136 1144 1128 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 1312 1321 1304 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g003">Figure 3D</xref>
###xml 1330 1340 1322 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">persephone</italic>
###xml 1376 1384 1368 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
To identify genetic modifiers of aminoglycoside-induced hair cell death, a standard F3 screening paradigm was used. Males were mutagenized with ethylnitrosourea following standard protocols [27], then crossed to wildtype females to produce F1 progeny. Mutagenesis was assessed by specific locus testing against unpigmented mitfa mutant animals [28], with a rate of about 1:300. F2 families were produced from F1 individuals, and F3 larvae produced by pairwise intercrosses within each family. F3 larvae were treated at 5 dpf with either high (200 microM) or low (25 microM) concentrations of neomycin for 30 minutes to identify mutants that exhibit protection or heightened susceptibility of hair cells, respectively. Hair cells were then assessed with the vital dye DASPEI, which is differentially taken up by neuromast hair cells [29],[30]. Figure 3 shows untreated and neomycin-exposed wildtype animals, and two mutants with altered susceptibility. In contrast to the wildtype subject (Figure 3B), persephone mutants (Figure 3C) show robust staining indistinguishable from an untreated animal (Figure 3A). Animals homozygous for the sentinel mutation also retain robust staining; in addition they display a linked morphological phenotype, a variable sinusoidal morphology that begins to be apparent by 3 dpf (Figure 3D). While persephone mutants are homozygous viable, the sentinel mutation is lethal at approximately 10-12 dpf.
###end p 21
###begin title 22
Mutations that confer protection against neomycin exposure.
###end title 22
###begin p 23
###xml 278 288 274 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">persephone</italic>
###xml 412 420 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Larvae are labeled with DASPEI after 30 min exposure to 200 microM neomycin and 1 hr recovery in normal media. (A) Wildtype animal shows retention of hair cells in neuromasts after mock-treatment. (B) Wildtype animal shows loss of hair cells after aminoglycoside treatment. (C) persephone mutant animal shows robust protection of neuromasts against neomycin treatment. No morphological defects are observed. (D) sentinel mutant animal shows protection, along with sinusoidal body curvature. Bar = 200 microm.
###end p 23
###begin p 24
###xml 652 662 652 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">persephone</italic>
###xml 664 678 664 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trainman, bane</italic>
###xml 718 739 718 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel, merovingian</italic>
###xml 769 780 769 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">merovingian</italic>
To date, we have identified 5 mutations that confer resistance and behave as simple recessive alleles. Complementation testing demonstrated that they affect different genes. We identified 5 additional mutations that confer resistance with more complex genetics, showing semi-dominant effects and/or interactions with modifying background loci. All mutations were transmitted to the next generation. We were surprised that all loci identified to date confer resistance, suggesting that affected genes normally act to promote cell death. The 5 simple recessive loci can be separated into two classes, mutations that have no apparent secondary phenotype (persephone, trainman, bane) and those with additional phenotypes (sentinel, merovingian). Animals homozygous for the merovingian mutation show reduced ear size and small otoliths (not shown).
###end p 24
###begin p 25
###xml 115 123 115 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g004">Figure 4</xref>
###xml 256 265 252 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g004">Figure 4A</xref>
###xml 616 628 612 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g004">Figure 4B&#8211;4F</xref>
###xml 690 693 686 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl</italic>
###xml 705 714 701 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g004">Figure 4D</xref>
###xml 786 802 782 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g004">Figure 4B and 4C</xref>
###xml 863 875 859 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g004">Figure 4D&#8211;4F</xref>
We have found that mutations differ dramatically in the relative resistance they confer against neomycin exposure (Figure 4). In wildtype animals, 200 microM neomycin exposure reliably reduces DASPEI staining to less than 10% of control untreated animals (Figure 4A). To examine the variability in phenotypes, we crossed heterozygous parents to produce offspring in typical Mendelian ratios (75% wildtype: 25% mutant progeny). Distributions show bimodality with robust DASPEI staining in 1/4 of the neomycin-treated progeny from crosses of heterozygous individuals for all 5 simple recessive mutations, as expected (Figure 4B-4F). Linked phenotypes cosegregate with resistance as shown for snl mutations (Figure 4D). Examples of mutations that confer near total resistance are shown in Figure 4B and 4C, and examples that confer only partial effects are shown in Figure 4D-4F. Partial protection may indicate that affected genes alter only one of several mechanisms involved in neomycin-induced cell death or that identified alleles may be hypomorphic and display only partial loss-of-function.
###end p 25
###begin title 26
Hair cell retention after neomycin treatment in wildtype and mutant animals.
###end title 26
###begin p 27
###xml 795 805 787 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">persephone</italic>
###xml 811 823 803 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">merovingian.</italic>
###xml 828 836 820 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 1047 1051 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bane</italic>
###xml 1057 1065 1049 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trainman</italic>
Histograms show the fraction of animals with different levels of DASPEI staining. For each animal, 10 specific neuromasts are evaluated and assigned a score of 2 (normal staining), 1 (reduced staining), or 0 (no staining) for a maximum total score of 0-20. For each group, the distribution of animals given each DASPEI staining score is displayed as a percentage of the total number of animals to illustrate the phenotypic variation within the group; 40-80 animals were tested for each group. (A) Distribution of wildtype fish after mock treatment without neomycin (green bars) or after exposure to 200 microM neomycin (blue bars). (B-F) Distribution of progeny from crosses between heterozygous mutant carriers treated with 200 microM neomycin, showing both wildtype and mutant phenotypes. (B) persephone. (C) merovingian. (D) sentinel. Animals with sinusoidal bodies (later shown to be homozygous mutants) are represented by orange bars, and animals with wildtype body shape (wildtype or heterozygous siblings) are represented by blue bars. (E) bane. (F) trainman.
###end p 27
###begin p 28
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 270 278 270 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 370 378 370 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g005">Figure 5</xref>
###xml 529 537 529 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 798 806 798 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 938 942 938 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Murakami1">[22]</xref>
###xml 1003 1011 1003 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 1024 1033 1024 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s001">Figure S1</xref>
The linked morphological features associated with sentinel mutants have allowed us to more fully characterize mutant phenotypes, since homozygous affected animals could be prospectively identified before directly testing the response to neomycin. We next tested whether sentinel mutants show altered response over the range of the aminoglycoside dose-response function (Figure 5). Animals were sorted by body phenotype as either wildtype or sinusoidal, and then exposed to different doses of neomycin. Animals homozygous for the sentinel mutation show robust, but partial, protection at all doses tested. Animals with wildtype body shape, including heterozygous mutants, are no different than the background *AB strain, demonstrating there are no effects of gene dosage. We also determined whether sentinel mutants show protection at later stages of development, since there are age-dependent differences in the dose-response to neomycin [22]. There is no change in the relative levels of protection by sentinel at 8-9 dpf (Figure S1), demonstrating that the mutation does not specifically confer protection by a general developmental delay.
###end p 28
###begin title 29
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Dose dependent protection of sentinel mutants to neomycin.
###end title 29
###begin p 30
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Hair cell loss as determined by DASPEI staining of progeny of sentinel heterozygous parents with wildtype body shape (blue) or sinusoidal body shape (red) are compared to wildtype *AB fish (green). Error bars are +/-1 S.D. Mutants show robust, but partial, protection following 30 min neomycin exposure and one hour recovery.
###end p 30
###begin title 31
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Molecular Identification of sentinel Mutation
###end title 31
###begin p 32
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl</italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl+</italic>
###xml 201 209 201 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Shimoda1">[31]</xref>
###xml 375 384 375 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6A</xref>
###xml 493 502 493 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6B</xref>
###xml 686 694 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 735 744 735 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6B</xref>
###xml 764 773 764 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6D</xref>
###xml 951 959 951 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 1020 1029 1020 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s002">Figure S2</xref>
###xml 1069 1077 1069 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 1161 1171 1161 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s002">Figure S2C</xref>
###xml 258 267 <span type="species:ncbi:7955">zebrafish</span>
###xml 1009 1018 <span type="species:ncbi:7955">zebrafish</span>
To determine the genetic location of the sentinel gene, we isolated 694 snl mutants and 234 snl+ siblings based on the neomycin response phenotype of their hair cells. We detected cosegregation of the sentinel phenotype with markers [31] on chromosome 23 of zebrafish. Analysis of recombinant chromosomes revealed a 41 kb linked genomic region containing one candidate gene (Figure 6A) predicted to encode a 1541 aa protein with 38 exons. The predicted exon and intron boundaries are shown in Figure 6B. The boundaries of the linked region are positioned within the coding region (within introns 8 and 33) of this novel gene. Sequence of the coding regions and exon-intron junctions in sentinel cDNAs revealed a stop codon in exon 14 (Figure 6B, red asterisk, and Figure 6D) in place of a tryptophan. This alteration is predicted to truncate the protein at amino acid 491 with loss of 68% of the protein and is likely to lead to loss of function. The sentinel transcript is expressed ubiquitously in wildtype zebrafish (Figure S2). We observed attenuated expression in sentinel mutants, perhaps indicating that nonsense-mediated decay of the transcript occurs (Figure S2C).
###end p 32
###begin title 33
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
The sentinel mutation creates a stop codon in a novel vertebrate gene.
###end title 33
###begin p 34
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl</italic>
###xml 803 811 803 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 885 893 885 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 990 998 990 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 260 269 <span type="species:ncbi:7955">zebrafish</span>
###xml 279 284 <span type="species:ncbi:10090">mouse</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
###xml 707 716 <span type="species:ncbi:7955">zebrafish</span>
###xml 935 944 <span type="species:ncbi:7955">zebrafish</span>
(A) A schematic of chromosome 23 region illustrates fraction of recombinant chromosomes among informative meioses for genetic markers defining the sentinel linked region (orange box). (B) Colored bars represent the genomic structures of the snl orthologs from zebrafish (green), mouse (red), and human (blue). Black boxes denote exons, with dotted lines connecting orthologous regions between species, and colored bars represent introns. Divergent exons encoding 5' UTR are shown as colored boxes. Three coding exons present only in the mammalian orthologs are noted with black arrows. Red rings highlight exons absent in human ortholog. The black arrowhead indicates the seven amino acids within exon 8 of zebrafish absent in the mammalian orthologs. A red asterisk marks the stop codon present in the sentinel allele within exon 14. (C), Phylogenetic tree of predicted proteins from sentinel orthologs. (D) cDNA sequence of wildtype zebrafish encoding tryptophan at amino acid 491 and of sentinel mutant bearing a stop codon. (E) Schematic of the predicted Sentinel protein including a C2 domain (yellow box) and a highly charged region (green box) with glutamine-rich basic clusters (blue boxes) flanking a lysine-rich acidic cluster (pink).
###end p 34
###begin p 35
###xml 201 210 201 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s003">Figure S3</xref>
###xml 599 608 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6C</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Nalefski1">[32]</xref>
###xml 950 959 950 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6E</xref>
###xml 1103 1112 1103 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g006">Figure 6E</xref>
###xml 17 26 <span type="species:ncbi:7955">zebrafish</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 251 260 <span type="species:ncbi:7955">zebrafish</span>
###xml 362 385 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 403 425 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 427 448 <span type="species:ncbi:5722">Trichomonas vaginalis</span>
###xml 453 475 <span type="species:ncbi:5888">Paramecium tetraurelia</span>
###xml 749 758 <span type="species:ncbi:7955">zebrafish</span>
Alignment of the zebrafish genomic region reveals homology to human (KIAA1345, 56% identity, 73% similarity) and mouse (RIKEN 5730509K17, 59% identity, 76% similarity) as well as to other vertebrates (Figure S3). The intron-exon structure between the zebrafish and mammalian orthologs is conserved with a few minor exceptions. We note looser homology to loci in Drosophila melanogaster, Aedes aegpytii, Caenorhabditis elegans, Trichomonas vaginalis and Paramecium tetraurelia genomes, suggesting that this is an ancient gene. The phylogenetic relationship between the predicted proteins is shown in Figure 6C. The Drosophila ortholog is annotated as two loci (CG18432 and CG18631) corresponding to the predicted N-terminal and C-terminal end of the zebrafish protein, indicating that they may encode a single transcript or be derived from a single ancestral locus. The predicted Sentinel protein contains a putative C2 domain [32] in the C-terminus (Figure 6E). The N-terminal third of the Sentinel protein is highly charged with two glutamine-rich acidic clusters flanking a lysine-rich basic cluster (Figure 6E). There is a notable absence of other recognizable domains.
###end p 35
###begin title 36
Genetic/Chemical Epistasis
###end title 36
###begin p 37
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl</italic>
###xml 343 346 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snl</italic>
###xml 406 414 398 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g007">Figure 7</xref>
###xml 462 470 454 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 759 767 747 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
To begin elucidating possible molecular pathways regulating susceptibility, we tested for an interaction between sentinel mutants and PROTO-1. Both PROTO-1 treatment and snl loss of function result in substantial but incomplete protection against neomycin exposure. We tested whether exposure of PROTO-1 conferred any additional protection to snl mutants when exposed to 100 microM or 200 microM neomycin. Figure 7 provides these results for siblings (left) and sentinel mutants (right), comparing hair cell counts in control animals and fish exposed to neomycin with or without pretreatment for 1 hr in 10 microM PROTO-1. At both doses of neomycin, treatment with PROTO-1 provides a small amount of additional protection, over and above that provided by the sentinel mutation. Analyses by one-way ANOVA followed by pair-wise comparisons (Fisher's PLSD test) revealed that at both doses the additional protection provided by PROTO-1 was statistically reliable (p<0.01), but that even the combined effect did not provide complete protection (p<0.01).
###end p 37
###begin title 38
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Epistasis analysis of sentinel and protective compounds.
###end title 38
###begin p 39
###xml 140 148 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 783 791 763 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Neomycin dose-response relationship showing effects of 10 microM PROTO-1 against 100 microM or 200 microM neomycin exposure in wildtype and sentinel larvae. For each group, hair cells were pre-labeled with FM1-43FX. Animals were pretreated with PROTO-1 for 1 hour (or mock-treated), treated with neomycin and PROTO-1 for 1 hour, euthanized, and fixed. Hair cells of four neuromasts (left and right) were counted and the average number of hair cells per neuromast was determined. Number of hair cells in control animals (no PROTO-1, no neomycin) are shown with black bars, animals treated with only 100 microM or 200 microM neomycin are shown by solid colored bars, and animals treated with PROTO-1 and neomycin are shown by hatched colored bars. Error bars show 1 S.E.M. PROTO-1 and sentinel mutants show similar protection, and there is a small, statistically significant effect of the combined treatment of the mutation plus PROTO-1.
###end p 39
###begin title 40
Determining Cellular Steps in Toxicity Altered by Modifiers
###end title 40
###begin p 41
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Marcotti1">[33]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Seiler1">[35]</xref>
###xml 366 370 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Santos1">[23]</xref>
Attenuation of drug-induced hair cell death could result from a number of causes that are not directly linked to the activation of cell death or cell survival pathways. Some examples include the well-established link between mechanotransduction-dependent activity and aminoglycoside uptake and susceptibility [33]-[35], the relative resistance seen in young animals [23], and abnormalities of aminoglycoside uptake.
###end p 41
###begin p 42
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Nishikawa1">[36]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Meyers1">[38]</xref>
###xml 190 198 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 263 271 263 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g008">Figure 8</xref>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s004">Figure S4</xref>
###xml 332 340 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 350 366 350 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g008">Figure 8B and 8D</xref>
###xml 414 430 414 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g008">Figure 8A and 8C</xref>
###xml 495 529 495 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s004">Figure S4A, Figure S4B, Figure S4C</xref>
###xml 669 677 669 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 715 736 715 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g008">Figure 8A and 8C to F</xref>
Rapid uptake of the vital dye FM 1-43 is commonly used as an indicator of sensory hair cell mechanotransduction [36]-[38]. We compared the uptake of FM1-43FX in control (wild-type) fish, in sentinel mutants and in wild-type fish treated with PROTO-1 and PROTO-2 (Figure 8; Figure S4). Rapid entry of FM1-43FX into the hair cells of sentinel mutants (Figure 8B and 8D) is comparable to that of wildtype hair cells (Figure 8A and 8C). Similarly, PROTO-1 and PROTO-2 did not alter FM1-43FX uptake (Figure S4A, Figure S4B, Figure S4C), indicating that mechanotransduction-associated events appear intact with these modulators. In addition, examination of the neuromasts in sentinel mutants by light microscopy (compare Figure 8A and 8C to Figure 8B and 8D) reveals that hair cells are organized in the stereotypical rosette pattern found in wildtype animals. Together these results suggest that these modifiers do not act by blocking hair cell transduction or slowing development.
###end p 42
###begin title 43
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
sentinel mutation does not affect transduction-dependent dye or aminoglycoside uptake.
###end title 43
###begin p 44
###xml 69 77 69 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
(A-D) Uptake of FM1-43FX after 45 sec exposure in wildtype (A,C) and sentinel mutants (B,D). Nuclei are labeled with Yo-Pro-1 (A-D). Confocal images of apical (A,B) and basal (C,D) optical sections through the hair cells. (E,F) Gentamicin-conjugated Texas Red uptake in wildtype (E) and sentinel mutant (F) animals after rapid 45 sec exposure.
###end p 44
###begin p 45
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Steyger1">[39]</xref>
###xml 197 213 197 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g008">Figure 8E and 8F</xref>
###xml 280 288 280 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 407 445 407 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000020.s004">Figure S4D, Figure S4E, and Figure S4F</xref>
To test whether these modifiers alter drug entry, we evaluated whether fluorescently-tagged aminoglycosides [39] enter hair cells in the presence of modifiers. Both the aminoglycosides gentamicin (Figure 8E and 8F) and neomycin (not shown) tagged with Texas Red fluorophore enter sentinel hair cells with a rapid, 45-second, exposure. Similarly, PROTO-1 and PROTO-2 did not alter labeled gentamicin uptake (Figure S4D, Figure S4E, and Figure S4F). While these results do not rule out subtle changes in aminoglycoside uptake, they do show that there are no dramatic differences that might account for the broad range of protection seen. Hence, it appears most likely that modifiers affect steps in toxicity that occur after aminoglycoside entry.
###end p 45
###begin p 46
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 373 381 373 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 468 477 468 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g009">Figure 9A</xref>
###xml 486 494 486 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 640 649 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g009">Figure 9B</xref>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 922 930 922 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Although the initial mechanism of hair cell death induced by aminoglycosides and cisplatin may be quite different, the later general cell death events are thought to be similar. To test whether these modulators alter cisplatin toxicity, we tested the effects of a range of cisplatin doses on sentinel mutants and on animals treated with PROTO-1. The response of sinusoidal sentinel mutants to cisplatin mirrored wildtype strains and siblings with wildtype body shape (Figure 9A). Thus, sentinel mutants are not protected against cisplatin-induced hair cell toxicity. Similarly, PROTO-1 did not protect against cisplatin-induced cell death (Figure 9B). The observation that sentinel mutants and fish exposed to PROTO-1 are relatively resistant to aminoglycoside-induced cell death but remain normally sensitive to cisplatin-induced cell death suggests that general cell death mechanisms are intact. We hypothesize that the sentinel mutation and PROTO-1 may abrogate aminoglycoside targets or early events in aminoglycoside-induced cell death that are not shared by cisplatin-induced cell death.
###end p 46
###begin title 47
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
sentinel mutation and PROTO-1 do not protect against cisplatin.
###end title 47
###begin p 48
###xml 335 343 333 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 456 464 454 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 501 509 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Hair cell survival was quantified using the vital dye DASPEI, and in each case DASPEI scores were normalized to those from wildtype, untreated fish. Fish (n>/=12 fish per treatment group) were treated in cisplatin for 4 hours, then allowed to recover for 3 hours prior to DASPEI assessment. (A) Hair cell responses in wild-type versus sentinel mutants. No difference in the dose-response relationship was observed between wildtype fish (green), homozygous sentinel mutants (red, sinusoidal body), and sentinel siblings (blue, including heterozygous and homozygous wildtype sibling, straight body). (B) Response of cisplatin-treated hair cells from wildtype fish in the presence of the potentially protective compound PROTO-1. There is no difference between dose-response curves with (red) and without (green) PROTO-1. Error bars represent +/-1 S.D.
###end p 48
###begin title 49
Modifier Test in Adult Mammalian Utricles
###end title 49
###begin p 50
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Cunningham1">[40]</xref>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Sugahara1">[42]</xref>
###xml 556 565 556 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000020-g010">Figure 10</xref>
###xml 71 80 <span type="species:ncbi:7955">zebrafish</span>
###xml 154 160 <span type="species:ncbi:10090">murine</span>
###xml 194 199 <span type="species:ncbi:10090">mouse</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
###xml 1127 1136 <span type="species:ncbi:7955">zebrafish</span>
Finally, we sought to determine whether modifiers we discovered in the zebrafish lateral line hair cell assay also confer protection to hair cells in the murine inner ear. While mutants for the mouse ortholog of sentinel are not yet available, a validated in vitro mammalian preparation of the mature mouse utricle has been used extensively to test protection of chemical modifiers [40]-[42]. We used the mouse utricle preparation to compare hair cell loss due to neomycin exposure between control utricles and utricles pretreated with PROTO-1 or PROTO-2. Figure 10 shows the neomycin dose-response relationship of striolar and extrastriolar hair cells in control utricles and utricles pretreated with PROTO-2. A two-factorial ANOVA (compound pretreatmentxneomycin) showed significant protection using PROTO-2 (p<0.0001) in both the striolar and extrastriolar hair cell populations. PROTO-1 protection against neomycin was tested at 4 mM neomycin and showed significant striolar (p<0.0001), but not significant extrastriolar, protection. These results suggest that modifiers that can be rapidly identified and validated in the zebrafish lateral line system can have application in understanding ototoxicity in the mammalian inner ear.
###end p 50
###begin title 51
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Protective compounds reduce neomycin toxicity in adult mouse utricle cultures.
###end title 51
###begin p 52
###xml 430 431 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
(A,B) Extrastriolar utricular hair cells stained with antibodies against calmodulin and calbindin after 4 mM neomycin exposure. An increased number of hair cells remain after PROTO-2 pretreatment (B) compared to control (A). (C,D) Neomycin dose-response curve showing effect of 10 microM PROTO-2 pretreatment on striolar (C) and extrastriolar (D) utricular hair cells. Counts were made at high magnification in areas of 900 microM2, converted to density, and averaged over the three sampled areas of each region for each utricle. Ten utricles were analyzed for each treatment group. Data were normalized relative to mock-treated controls (no PROTO drug, no neomycin).
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Guan1">[15]</xref>
###xml 829 834 <span type="species:ncbi:9606">human</span>
###xml 922 927 <span type="species:ncbi:9606">human</span>
Mechanosensory hair cells in the inner ear are susceptible to a wide variety of environmental insults. However, the large amount of variation in hearing and balance problems resulting from environmental or age-related challenges among normal individuals is neither well documented nor well understood. There is even large variance among individuals with the A1555G mutation in the mitochondrial 12S rRNA that increases susceptibility to neomycin toxicity [15]. We hypothesize that alterations in unidentified components of the network of cellular pathways involved in cell death and cell survival would confer resistance to ototoxic compounds. The absence of secondary phenotypes in some of our mutants supports the idea that variation affecting drug response can exist without other outward manifestation. Identification of the human orthologs of these genes may provide candidates involved in the variability underlying human hearing and balance disorders.
###end p 54
###begin p 55
###xml 293 301 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 500 508 500 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Owens1">[43]</xref>
Our data suggest that hair cell death after neomycin treatment can involve multiple signaling pathways. Several mutations confer only partial protection against neomycin exposure. Although in some cases this might result from mutations that cause only partial loss of function, in the case of sentinel we suspect that the mutation is a functional null. The mutation introduces a stop codon early in the coding sequence and before the highly conserved regions. In addition, mRNA levels are reduced in sentinel mutants, suggesting nonsense-mediated decay. Together these observations suggest that gene function is completely lost, while protection against hair cell loss is only partial. Similarly, only partial protection is observed after treatment with maximal doses of PROTO-1 or PROTO-2. The idea that there are several possible responses to aminoglycosides is consistent with our previous observed variations in ultrastructural changes after aminoglycoside exposure [43].
###end p 55
###begin p 56
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Rybak1">[11]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Wu1">[44]</xref>
###xml 402 410 402 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
The sentinel mutation also genetically distinguishes between aminoglycoside-induced and cisplatin-induced death; mutant animals are resistant to neomycin but still sensitive to cisplatin. Both aminoglycoside and cisplatin exposure have been proposed to result in oxidative stress [11],[44], raising the possibility that ototoxic compounds share similar mechanisms. If such shared mechanisms occur, the sentinel gene product must act upstream of these events. Treatment with PROTO-1 also offered no protection against cisplatin, suggesting that its cellular target acts specifically during aminoglycoside toxicity.
###end p 56
###begin p 57
###xml 16 24 16 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 456 464 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Inactivation of sentinel and treatment with PROTO-1 similarly alter the response of hair cells to neomycin treatment. Both modulators offer only partial protection against neomycin, offer no protection against cisplatin, and do not affect entry of FM1-43 or labeled aminoglycoside. Together these results suggest they work in common pathways. To test this idea, we performed epistasis experiments treating wildtype and mutant animals. While the effects of sentinel and PROTO-1 are not additive, there is a small but significant increase in protection when combined, suggesting that they may be accessing different cellular pathways to promote cell survival. Understanding similarities and differences among possible pathways will await the identification of the cellular targets of PROTO-1.
###end p 57
###begin p 58
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 153 161 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 274 282 274 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Nalefski1">[32]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-AvidorReiss1">[45]</xref>
###xml 1197 1201 1197 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Blacque1">[46]</xref>
###xml 1509 1517 1509 1517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 667 682 <span type="species:ncbi:7227">D. melanogaster</span>
###xml 1078 1088 <span type="species:ncbi:6239">C. elegans</span>
###xml 1221 1230 <span type="species:ncbi:7955">zebrafish</span>
The identification of the sentinel gene highlights one strength of forward genetic screening, as it would be difficult or impossible to choose this gene a priori as a candidate regulator of mechanosensory hair cell death. No functional information is known about any of the sentinel orthologs. The only functional domain of note, the C2 domain, has been associated with calcium regulation and interaction with phospholipid membranes in signaling proteins such as protein kinase C or membrane trafficking proteins like Synaptotagmin [32]. However, the function of this domain has been demonstrated in only a few of the many proteins that contain it. Intriguingly, the D. melanogaster ortholog CG18631 was identified in a comparative bioinformatics screen as being associated with compartmentalized cilia-bearing organisms suggesting it may have a role in regulation of cilia [45]. Other members of this group include molecules related to intraflagellar transport (IFT) proteins and Bardet-Biedl syndrome (BBS)-related proteins associated with auditory function. In addition, the C. elegans K07G5.3 ortholog is enriched in ciliated neurons by SAGE analysis and localizes to ciliated sensory neurons [46]. Hair cells of the zebrafish lateral line and inner ear are also ciliated, bearing a microtubule-based kinocilium in addition to the actin-based stereocilia either throughout life (lateral line and vestibular epithelia) or during development (auditory epithelia/cochlea). However, the broad distribution of sentinel mRNA and lack of hair cell functional defects in mutants suggest that the gene product does not have a role specific to hair cells.
###end p 58
###begin p 59
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-North1">[47]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Critchfield1">[48]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Wang1">[50]</xref>
###xml 250 259 <span type="species:ncbi:7955">zebrafish</span>
###xml 597 600 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In addition to identifying possible therapeutic approaches, unbiased small molecule screening may reveal new molecular pathways that regulate hair cell death. This approach has been taken previously in a small molecule screen for compounds affecting zebrafish blood development; by identifying several compounds that affected prostaglandin metabolism, PGE2 was revealed as a regulator of haematopoiesis [47]. PROTO-1 and PROTO-2 are related benzothiophene carboxamides, suggesting that they may have the same molecular targets. Other benzothiophene carboxamides have previously been identified as HIV inhibitors, having effects on casein kinase, calcineurin and p53 [48]-[50]. Further work will be needed to determine whether any of these pathways modulate hair cell death.
###end p 59
###begin p 60
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Weinshilboum1">[51]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Humbert1">[52]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Rieder1">[53]</xref>
Perhaps the most important contribution here is the suggestion that our screens can serve as templates for other research programs to identify other gene-drug interactions. Individuals respond remarkably differently to environmental exposures and drug treatment in most disease conditions. Efforts to understand population variation have centered on epidemiological and pharmacogenomic approaches [51]. However there are only a few cases in which the genes responsible for this phenotypic variability have been identified, such as for VKORC1-warfarin response or PON1-organophosphate toxicity [52],[53]. Genetic analysis may provide a systematic method to identify new molecules involved in cellular responses to drugs or disease.
###end p 60
###begin title 61
Materials and Methods
###end title 61
###begin title 62
Animals
###end title 62
###begin p 63
###xml 19 30 19 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Westerfield1">[54]</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 19 30 <span type="species:ncbi:7955">Danio rerio</span>
###xml 110 119 <span type="species:ncbi:7955">zebrafish</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
Zebrafish embryos (Danio rerio) were produced by paired matings of adult fish in the University of Washington zebrafish facility by standard methods [54]. The *AB and WIK wildtype strains are maintained individually as inbred lines. Three to six-week-old CBA/CaJ mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained in the University of Washington Animal Care facility. All animal protocols were approved by the University of Washington Animal Care Committee.
###end p 63
###begin title 64
Vital Dye Staining
###end title 64
###begin p 65
Larvae were transferred manually to baskets in 6-well culture plates containing defined E2 embryo medium. Baskets were constructed from the tops of 50 ml Falcon tubes in which the center of the lids were replaced with meshing. All treatment and wash volumes are 6 ml unless otherwise indicated. Hair cells of larvae were labeled with the following dyes: 1) FM 1-43FX (n-(3,3-ammoniumpropyl-dimethyl)ammoniumpropyl)-4-(4-(dibutylamino)styryl) pyridinium trichloride), an aminated derivative of FM1-43 (n-(3-triethylyammoniumpropyl)-4-(4-(dibutylamino)-styryl) pyridinium dibromide Invitrogen Molecular Probes, Eugene , OR) by immersing free swimming larvae in 3 microM FM 1-43FX in embryo medium for 30 or 45 s, followed by three successive rinses in embryo medium; 2) Yo-Pro-1 (Invitrogen Molecular Probes) at 3 microM for 1 hour followed by 3 rinses to selectively stain hair cell nuclei; or 3) DASPEI (0.005% final concentration, (2-{4-(dimethylamino)styryl}-N-ethylpyridinium iodide, Invitrogen Molecular Probes) in the final 15 minutes of the recovery period, and rinsed twice to brightly label mitochondria-rich hair cell cytoplasm. Larvae were anesthetized with MS222 (3-aminobenzoic acid ethyl ester, methansulfoneate salt, Sigma-Aldrich, St. Louis, Missouri) at a final concentration of 0.02% prior to imaging.
###end p 65
###begin title 66
Neomycin Treatment
###end title 66
###begin p 67
Neomycin (Sigma-Aldrich, catalog no. N1142) was diluted in defined E2 embryo medium. Animals were treated with drug or embryo media (mock-treated controls) for times indicated, subsequently washed rapidly three times in fresh embryo medium and allowed to recover for one hour.
###end p 67
###begin title 68
Cisplatin Treatment
###end title 68
###begin p 69
###xml 25 34 <span type="species:ncbi:7955">zebrafish</span>
For cisplatin treatment, zebrafish larvae were exposed to 0-400 microM cisplatin (Sigma-Aldrich, catalog no. P4394) for 4 hours, rinsed several times in embryo medium and held 3 hours in the same media prior to DASPEI staining and visualization.
###end p 69
###begin title 70
Compound Screening
###end title 70
###begin p 71
Larvae were stained with Yo-Pro-1 and FM 1-43 and then dispensed into 96-well glass bottom plates (Nunc, Rochester, New York) containing embryo medium (1-2 fish per well). Drug-like compounds from the Diverset E library (ChemBridge,San Diego, California), dissolved in 0.05% DMSO to a final concentration of 10 microM, were aliquoted into each well. Fish were incubated at 28.5degreesC for 1 hour. Neomycin was then introduced into each well at a final concentration of 200 microM and fish were incubated for an additional hour. Larvae were anesthetized with MS222 for immobilization. Visual assessment of hair cell integrity was performed in vivo using an inverted epifluorescent microscope. This allowed examination of the whole animal on the side of its body facing the objective and thus rapid evaluation of many neuromasts (approximately20). In each row of the 96-well plate both positive (neomycin treated only) and negative (no neomycin) control animals were used for comparison to compound treatment. The entire plate of 96-well plate with 80 test wells and 16 positive or negative control wells was evaluated within one hour. Although intermediate responses were observed for some drugs, only those exhibiting robust protection were pursued for continued evaluation at this time.
###end p 71
###begin p 72
To quantify changes in the hair cell response, hair cell survival was determined by counting the surviving hair cells from four neuromast, SO1, SO2, OC1 and O1 for 10-20 fish (i.e. 40-80 neuromasts). The percentage of surviving hair cells following treatment was calculated relative to mock-treated controls (no drugs or neomycin exposure).
###end p 72
###begin title 73
Minimum Inhibitory and Bactericidal Concentration Assays
###end title 73
###begin p 74
###xml 357 361 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Wikler1">[55]</xref>
###xml 362 366 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Wikler2">[56]</xref>
Determination of the minimum inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) of neomycin alone and in the presence of 10 microM PROTO-1 or PROTO-2 were performed at the Clinical Laboratory of Microbiology at the University of Washington Medical Center as described by the National Clinical and Laboratory Standards Institute [55],[56].
###end p 74
###begin title 75
ENU Mutagenesis
###end title 75
###begin p 76
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-SolnicaKrezel1">[27]</xref>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nacre</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nacre</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mitfa</italic>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Lister1">[28]</xref>
Adult males from the *AB wildtype strain were mutagenized with 3 mM ethylnitrosourea (ENU) using standard procedures [27]). To assess the effectiveness of the mutagenesis, we performed a specific locus test of mutagenized males with homozygous nacre females; mutation of the nacre (mitfa) gene results in lack of pigment, which is readily apparent [28]. The ratio of progeny with a nacre-like pigment phenotype to total progeny was 1/300. Mutagenized males were then crossed to wildtype *AB females to produce F1 progeny. F2 families were derived from pairwise matings of F1 progeny of different mutagenized males.
###end p 76
###begin title 77
Genetic Screen
###end title 77
###begin p 78
###xml 430 434 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Harris1">[21]</xref>
For each family screened, three to twelve F2 pairs were crossed and their progeny were examined for altered aminoglycoside response. Neomycin doses of 25 microM or 200 microM were used to screen for heightened susceptibility or protection, respectively. Ten neuromasts were evaluated on each fish for DASPEI staining and each neuromast was assigned a score of 0 for no/little staining, 1 for reduced staining, 2 for full staining [21], resulting in a final score of 0-20 for each fish. Scores were averaged and normalized to mock-treated controls. For initial analysis, 12-50 fish were assessed for typical and atypical responders (i.e. 120-500 neuromasts). Results were tabulated and chi-squared analysis was done to identify potential mutant strains of interest. Putative mutants were retested to confirm phenotype, outcrossed to *AB fish and tested again in the next generation to confirm transmission.
###end p 78
###begin title 79
Genetic Mapping
###end title 79
###begin p 80
###xml 737 741 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Shimoda1">[31]</xref>
###xml 1335 1343 1331 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 1379 1383 1375 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snp3</italic>
###xml 1431 1438 1427 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sat3334</italic>
###xml 61 70 <span type="species:ncbi:7955">zebrafish</span>
###xml 1208 1217 <span type="species:ncbi:7955">Zebrafish</span>
Heterozygous mutant carriers were outcrossed to the wildtype zebrafish from the polymorphic WIK strain for mapping. Hybrid *AB/WIK carriers of the hair cell modulator were then identified and crossed to produce progeny for marker analysis. At 5 dpf larvae were exposed to neomycin as described for the initial screen. To ensure accurate phenotyping, only individuals with the highest and lowest DASPEI staining scores after 200 microM neomycin treatment were retained as mutant and wildtype, respectively. For bulk segregant analysis, DNA was pooled from 20 wildtype or mutant individuals. Distribution of markers was compared to DNA from fin clips of *AB/WIK parents and founder grandparents. Microsatellite markers for each chromosome [31] were amplified by PCR and evaluated for cosegregation with mutant phenotypes. Linked markers were further evaluated with individual DNAs from 694 mutant fish and 234 wildtype fish (including both heterozygous and homozygous wildtype siblings). After determining initial linkage to chromosome 23, fine mapping identified Z3794 and Z44679 as flanking markers. A contiguous genomic sequence was then assembled using whole genome shotgun trace sequences produced by the Zebrafish Sequencing Group at the Sanger Institute (). Additional markers were developed to better define the linked region in sentinel mutants based on genomic sequence. snp3 amplifies a single nucleotide polymorphism and sat3334 is a sequence length polymorphism. They are amplified by the primers:
###end p 80
###begin p 81
###xml 14 38 14 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGGTGTCGAACTTGCACCTTTAAT</named-content>
snp3_forward: GGGTGTCGAACTTGCACCTTTAAT
###end p 81
###begin p 82
###xml 14 39 14 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTTGCTTAATTAGGCCTACAGCACT</named-content>
snp3_reverse: GTTGCTTAATTAGGCCTACAGCACT
###end p 82
###begin p 83
###xml 17 37 17 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTTCATTCGCCCTCTGAACC</named-content>
sat3334_forward: CTTCATTCGCCCTCTGAACC
###end p 83
###begin p 84
###xml 17 39 17 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GTGCACACTGTGATGTCGATAA</named-content>
sat3334_reverse: GTGCACACTGTGATGTCGATAA
###end p 84
###begin title 85
cDNA Isolation and Sequencing/Molecular Biology
###end title 85
###begin p 86
RNA was isolated from whole embryos at 62 hpf using Trizol according to manufacturer's specifications (Invitrogen, Carlsbad, California). Oligonucleotide primers were designed based on in silico genomic sequence. cDNA was synthesized using First Strand cDNA synthesis kit (Invitrogen) using oligo DT primers. The following primer pairs were used to amplify portion of cDNA spanning the recombination breakpoints:
###end p 86
###begin p 87
###xml 16 37 16 37 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGGTTGAGGCTGGTTTGCCGA</named-content>
pair 1 forward: AGGTTGAGGCTGGTTTGCCGA
###end p 87
###begin p 88
###xml 16 41 16 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTCTCAGTGCTTTCAGCTCCTTCCA</named-content>
pair 1 reverse: CTCTCAGTGCTTTCAGCTCCTTCCA
###end p 88
###begin p 89
###xml 16 41 16 41 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGTCAGACACACTCGACAGTTGCG</named-content>
pair 2 forward: TTGTCAGACACACTCGACAGTTGCG
###end p 89
###begin p 90
###xml 16 38 16 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGGGGTCGAGGCGAGATTCTG</named-content>
pair 2 reverse: TTGGGGTCGAGGCGAGATTCTG
###end p 90
###begin p 91
###xml 16 38 16 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGATGGACGCCATCGCTTGCAT</named-content>
pair 3 forward: AGATGGACGCCATCGCTTGCAT
###end p 91
###begin p 92
###xml 16 38 16 38 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCGTTCCAGCAGGGGTTTGGAC</named-content>
pair 3 reverse: TCGTTCCAGCAGGGGTTTGGAC
###end p 92
###begin p 93
Amplified products were cloned into pCR4 vectors using Topo TA cloning kit (Invitrogen). cDNA and genomic regions were sequenced from the vector T3 or T7 sites using Big Dye terminator v3.1 cycle sequencing chemistry (Applied Biosystems, Foster City, California).
###end p 93
###begin title 94
Comparative Genomics
###end title 94
###begin p 95
###xml 391 402 391 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 447 459 447 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 487 499 487 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 529 544 529 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pan troglodytes</italic>
###xml 575 591 575 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Canis familiaris</italic>
###xml 617 627 617 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bos taurus</italic>
###xml 705 718 705 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gallus gallus</italic>
###xml 745 767 745 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caenorhabditis elegans</italic>
###xml 794 817 794 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila melanogaster</italic>
###xml 866 880 866 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aedes aegyptii</italic>
###xml 906 927 906 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trichomonas vaginalis</italic>
###xml 957 979 957 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paramecium tetraurelia</italic>
###xml 1137 1141 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Chenna1">[57]</xref>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Felsenstein1">[58]</xref>
###xml 1539 1543 1539 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Page1">[59]</xref>
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
###xml 391 402 <span type="species:ncbi:7955">Danio rerio</span>
###xml 447 459 <span type="species:ncbi:10090">Mus musculus</span>
###xml 487 499 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 529 544 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 575 591 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 617 627 <span type="species:ncbi:9913">Bos taurus</span>
###xml 654 675 <span type="species:ncbi:13616">Monodelphis domestica</span>
###xml 705 718 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 745 767 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 794 817 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 906 927 <span type="species:ncbi:5722">Trichomonas vaginalis</span>
###xml 957 979 <span type="species:ncbi:5888">Paramecium tetraurelia</span>
Zebrafish cDNAs were aligned to known ESTs, cDNAs and genomic sequence from this region using Sequencher software (Gene Codes, Ann Arbor, Michigan). BLAST alignments of our cDNA sequences align with predicted cDNA (Genbank XM_693709/gi:125851476) amino acids 75-1040. Orthologs were identified from Genbank using BLAST and the corresponding predicted protein sequences were aligned with the Danio rerio predicted protein (XP_698801/gi:125851477): Mus musculus (NP_758478.1/gi:26986583), Homo sapiens (NP_001073991/gi:122937494), Pan troglodytes (XP_001159814 /gi:114593231), Canis familiaris (XP_536233/gi:73951827), Bos taurus (XP_595408/gi:119894226), Monodelphis domestica (XP_001369774/gi:126331991), Gallus gallus (XP_420777/gi:118090694), Caenorhabditis elegans (NP_492026/gi:U17508151), Drosophila melanogaster (NP_611229 and NP_611230/gi:24654454/28573534), Aedes aegyptii (EAT41051/gi:108876826), Trichomonas vaginalis (XP_001323414/gi:123480792), Paramecium tetraurelia (CAK70738/gi:124405296). ClustalW multiple sequence alignment software was used to align predicted proteins of orthologous genes using the Gonnet 250 matrix [57]. We used the Phylip 3.66 phylogeny software [58] to create a bootstrapped data set from the original alignment using Seqboot, then Protml to evaluate these datasets using the maximum likelihood method with a Jones-Taylor-Thorton model of amino acid substitution. A consensus tree was determined with Consense software by extended majority rule. Phylogenetic trees were draw with TreeView software [59]. Protein motif searching was performed using the Eukaryotic Linear Motif server (elm.eu.org).
###end p 95
###begin title 96
Gentamicin-Texas Red Conjugation
###end title 96
###begin p 97
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Steyger1">[39]</xref>
4.4 ml of gentamicin sulfate (Sigma-Aldrich, 50 mg/ml) and 0.6 ml succinimidyl esters of Texas Red (Molecular Probes, Eugene, Oregon; 2 mg/ml in dimethyl formamide) were agitated overnight to produce the conjugate solution [39]. The conjugated solution was diluted in embryo media to a final concentration of 200 microM gentamicin. Because neomycin contains six amino side groups, neomycin conjugation was performed similarly except that the ratio of neomycin to Texas Red was adjusted to 3:1 to ensure that on average one molecule of dye or less labeled each aminoglycoside molecule. To assess aminoglycoside entry, 5 dpf larvae were immersed in aminoglycoside-Texas Red conjugate for 45 seconds and rinsed in embryo medium four times before immediate imaging. Images were collected using Zeiss LSM5 Pascal confocal microscope. Z-stack images of neuromasts were collected.
###end p 97
###begin title 98
Utricle Preparation
###end title 98
###begin p 99
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000020-Cunningham1">[40]</xref>
###xml 121 127 <span type="species:ncbi:9913">bovine</span>
Utricles were dissected and cultured in basal medium EAGLE supplemented with Earle's balanced salt solution and 5% fetal bovine serum following established procedures [40]. Neomycin sulfate stock solution (Sigma-Aldrich) prepared in sterile water was added directly to culture wells at the desired concentrations. The utricles were incubated for 4 hours in the compounds diluted with 0.05% DMSO or 0.05% DMSO alone for controls followed by a 24 hour incubation with neomycin.
###end p 99
###begin title 100
Utricle Immunohistochemistry
###end title 100
###begin p 101
###xml 1247 1248 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 263 269 <span type="species:ncbi:9913">bovine</span>
###xml 297 301 <span type="species:ncbi:9925">goat</span>
###xml 321 326 <span type="species:ncbi:9796">horse</span>
###xml 783 788 <span type="species:ncbi:9796">horse</span>
###xml 794 799 <span type="species:ncbi:10090">mouse</span>
###xml 837 841 <span type="species:ncbi:9925">goat</span>
###xml 847 853 <span type="species:ncbi:9986">rabbit</span>
###xml 963 968 <span type="species:ncbi:10090">mouse</span>
Utricles were fixed for 1 hour at 4degreesC in 4% paraformaldehyde in phosphate buffer. Following fixation, otoconia were removed by gently "washing" the surface with buffer through a 26 gauge syringe needle. Utricles were then incubated in blocking solution (2% bovine serum albumin, 0.4% normal goat serum, 0.4% normal horse serum and 0.4% Triton-X in PBS) for 3 hours at room temperature. Hair cells were double labeled in whole-mount preparations with a monoclonal antibody against calmodulin (Sigma-Aldrich) and polyclonal antibody against calbindin (Chemicon, Temecula, California) at 4degreesC diluted in blocking solution, 1:250. The utricles were then rinsed and incubated for 2 hours at room temperature in secondary antibody diluted in blocking solution with biotinylated horse anti-mouse IgG (1:200) and Alexa 594-conjugated goat anti-rabbit IgG. Utricles were mounted with Fluoromount-G (EMS, Hatfield, Pennsylvania) and coverslipped. The density of mouse utricular hair cells was determined by counting the number of hair cells in three randomly chosen nonstriolar regions and the number of striolar hair cells in three randomly chosen striolar regions from each utricle. Counts were made at high magnification in areas of 900 microM2, converted to density, and averaged over the three sampled areas of each region for each utricle. Ten utricles were analyzed in this way for each treatment group. Data were normalized relative to mock-treated controls (no PROTO drug, no neomycin).
###end p 101
###begin title 102
Supporting Information
###end title 102
###begin p 103
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Comparison of the dose response curve of 5 dpf versus 8-9 dpf sentinel mutants. Hair cell staining by DASPEI was assessed after neomycin exposure among progeny of sentinel heterozygous parents with wildtype body shape (blue) or sinusoidal body shape (red). The dose response curves of wildtype *AB control fish are shown (green). (A) Dose-response at 5 dpf. (B) Dose-response at 8-9 dpf. Error bars are {plus minus}1 S.D. Found at doi:10.1371/journal.pgen.0040041.sd001 (252 KB AI).
###end p 103
###begin p 104
(0.26 MB AI)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sentinel</italic>
Figure S2. In situ hybridization of biotinylated probes to the sentinel locus reveals ubiquitous expression. (A) Wildtype *AB larvae 64 hpf, antisense probe. (B) *AB larvae 64 hpf, sense probe. (C) sentinel mutants 64 hpf, antisense probe.
###end p 106
###begin p 107
(1.69 MB AI)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 47 58 47 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Danio rerio</italic>
###xml 85 97 85 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 127 139 127 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 47 58 <span type="species:ncbi:7955">Danio rerio</span>
###xml 85 97 <span type="species:ncbi:10090">Mus musculus</span>
###xml 127 139 <span type="species:ncbi:9606">Homo sapiens</span>
Aligned sequence of Sentinel-related proteins. Danio rerio (XM_693709/gi:125851477), Mus musculus (NP_758478/gi:26986583), and Homo sapiens (NP_001073991/gi:122937494).
###end p 109
###begin p 110
(0.03 MB DOC)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
Protective compounds do not affect transduction-dependent dye or aminoglycoside uptake. (A-C) Rapid entry (45 sec) of 3 microM FM 1-43 (red) into untreated (A), PROTO-1 (B), or PROTO-2 (C) treated hair cells. Nuclei are labeled with Yo-Pro-1 (green). (D-F) Exposure to gentamicin-conjugated Texas Red results in rapid labeling of untreated (D), 10 microM PROTO-1 (E), or PROTO-2 (F) pretreated hair cells.
###end p 112
###begin p 113
(5.40 MB AI)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
We thank L. Cunningham for early input, A. Nechiporuk for assistance in mutagenesis, Glen MacDonald, Dale Cunningham, Mae del Puerto, Tonibelle Gatbonton, J. Itani, M. Nasry, and K. Reinhart for technical assistance, S. McFarlane for EM sectioning, and D. White and T. Huyhn for animal care.
###end p 115
###begin title 116
References
###end title 116
###begin article-title 117
Genetic associations in age-related hearing thresholds.
###end article-title 117
###begin article-title 118
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Strain background effects and genetic modifiers of hearing in mice.
###end article-title 118
###begin article-title 119
###xml 56 64 <span type="species:ncbi:9606">children</span>
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
###end article-title 119
###begin article-title 120
###xml 15 20 <span type="species:ncbi:9606">human</span>
Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature.
###end article-title 120
###begin article-title 121
Genetic epidemiologic study of hearing loss in an adult population.
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human nonsyndromic sensorineural deafness.
###end article-title 122
###begin article-title 123
###xml 54 62 <span type="species:ncbi:9606">patients</span>
A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome).
###end article-title 123
###begin article-title 124
###xml 58 63 <span type="species:ncbi:9606">human</span>
Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous.
###end article-title 124
###begin article-title 125
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13).
###end article-title 125
###begin article-title 126
Aminoglycoside antibiotics.
###end article-title 126
###begin article-title 127
Mechanisms of cisplatin-induced ototoxicity and prevention.
###end article-title 127
###begin article-title 128
Vestibular and cochlear toxicity of aminoglycosides-a review.
###end article-title 128
###begin article-title 129
Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide.
###end article-title 129
###begin article-title 130
Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness.
###end article-title 130
###begin article-title 131
Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation.
###end article-title 131
###begin article-title 132
A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity.
###end article-title 132
###begin article-title 133
Hair cell death in the avian basilar papilla: characterization of the in vitro model and caspase activation.
###end article-title 133
###begin article-title 134
###xml 20 29 <span type="species:ncbi:7955">zebrafish</span>
The lateral line of zebrafish: a model system for the analysis of morphogenesis and neural development in vertebrates.
###end article-title 134
###begin article-title 135
###xml 39 48 <span type="species:ncbi:7955">zebrafish</span>
The genetics of hearing and balance in zebrafish.
###end article-title 135
###begin article-title 136
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish as a model for hearing and deafness.
###end article-title 136
###begin article-title 137
###xml 79 88 <span type="species:ncbi:7955">zebrafish</span>
###xml 90 101 <span type="species:ncbi:7955">Danio rerio</span>
Neomycin-induced hair cell death and rapid regeneration in the lateral line of zebrafish (Danio rerio).
###end article-title 137
###begin article-title 138
###xml 114 123 <span type="species:ncbi:7955">zebrafish</span>
###xml 125 136 <span type="species:ncbi:7955">Danio rerio</span>
Developmental differences in susceptibility to neomycin-induced hair cell death in the lateral line neuromasts of zebrafish (Danio rerio).
###end article-title 138
###begin article-title 139
###xml 87 96 <span type="species:ncbi:7955">zebrafish</span>
###xml 98 109 <span type="species:ncbi:7955">Danio rerio</span>
Lateral line hair cell maturation is a determinant of aminoglycoside susceptibility in zebrafish (Danio rerio).
###end article-title 139
###begin article-title 140
###xml 31 40 <span type="species:ncbi:7955">zebrafish</span>
Cell turnover in neuromasts of zebrafish larvae.
###end article-title 140
###begin article-title 141
###xml 36 45 <span type="species:ncbi:7955">zebrafish</span>
###xml 47 58 <span type="species:ncbi:7955">Danio rerio</span>
Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line.
###end article-title 141
###begin article-title 142
###xml 11 20 <span type="species:ncbi:7955">zebrafish</span>
The use of zebrafish for assessing ototoxic and otoprotective agents.
###end article-title 142
###begin article-title 143
###xml 53 62 <span type="species:ncbi:7955">zebrafish</span>
Efficient recovery of ENU-induced mutations from the zebrafish germline.
###end article-title 143
###begin article-title 144
###xml 16 25 <span type="species:ncbi:7955">zebrafish</span>
nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate.
###end article-title 144
###begin article-title 145
Regenerated hair cells can originate from supporting cell progeny: evidence from phototoxicity and laser ablation experiments in the lateral line system.
###end article-title 145
###begin article-title 146
Dimethylaminostyrylmethylpyridiniumiodine (daspmi) as a fluorescent probe for mitochondria in situ.
###end article-title 146
###begin article-title 147
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish genetic map with 2000 microsatellite markers.
###end article-title 147
###begin article-title 148
The C2 domain calcium-binding motif: structural and functional diversity.
###end article-title 148
###begin article-title 149
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels.
###end article-title 149
###begin article-title 150
Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells.
###end article-title 150
###begin article-title 151
###xml 59 68 <span type="species:ncbi:7955">zebrafish</span>
Defective calmodulin-dependent rapid apical endocytosis in zebrafish sensory hair cell mutants.
###end article-title 151
###begin article-title 152
###xml 81 88 <span type="species:ncbi:8355">Xenopus</span>
Internalization of styryl dye FM1-43 in the hair cells of lateral line organs in Xenopus larvae.
###end article-title 152
###begin article-title 153
FM1-43 dye behaves as a permeant blocker of the hair-cell mechanotransducer channel.
###end article-title 153
###begin article-title 154
Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels.
###end article-title 154
###begin article-title 155
###xml 24 32 <span type="species:ncbi:8400">bullfrog</span>
Uptake of gentamicin by bullfrog saccular hair cells in vitro.
###end article-title 155
###begin article-title 156
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Caspase activation in hair cells of the mouse utricle exposed to neomycin.
###end article-title 156
###begin article-title 157
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Overexpression of Bcl-2 prevents neomycin-induced hair cell death and caspase-9 activation in the adult mouse utricle in vitro.
###end article-title 157
###begin article-title 158
JNK signaling in neomycin-induced vestibular hair cell death.
###end article-title 158
###begin article-title 159
###xml 74 83 <span type="species:ncbi:7955">zebrafish</span>
Ultrastructural analysis of aminoglycoside-induced hair cell death in the zebrafish lateral line reveals an early mitochondrial response.
###end article-title 159
###begin article-title 160
Recent advances in understanding aminoglycoside ototoxicity and its prevention.
###end article-title 160
###begin article-title 161
Decoding cilia function: defining specialized genes required for compartmentalized cilia biogenesis.
###end article-title 161
###begin article-title 162
Functional genomics of the cilium, a sensory organelle.
###end article-title 162
###begin article-title 163
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.
###end article-title 163
###begin article-title 164
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Casein kinase II is a selective target of HIV-1 transcriptional inhibitors.
###end article-title 164
###begin article-title 165
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 113 116 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties.
###end article-title 165
###begin article-title 166
Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.
###end article-title 166
###begin article-title 167
Pharmacogenetics and pharmacogenomics: development, science, and translation.
###end article-title 167
###begin article-title 168
###xml 27 32 <span type="species:ncbi:9606">human</span>
The molecular basis of the human serum paraoxonase activity polymorphism.
###end article-title 168
###begin article-title 169
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.
###end article-title 169
###begin article-title 170
###xml 4 13 <span type="species:ncbi:7955">Zebrafish</span>
###xml 54 63 <span type="species:ncbi:7955">zebrafish</span>
###xml 65 76 <span type="species:ncbi:7955">Danio rerio</span>
The Zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio).
###end article-title 170
###begin article-title 171
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically.
###end article-title 171
###begin article-title 172
Performance Standards for Antimicrobial Susceptibility Testing.
###end article-title 172
###begin article-title 173
Multiple sequence alignment with the Clustal series of programs.
###end article-title 173
###begin article-title 174
PHLYIP-Phlylogeny Interference Package (version 3.2).
###end article-title 174
###begin article-title 175
TreeView: an application to display phylogenetic trees on personal computers.
###end article-title 175
###begin p 176
The authors have declared that no competing interests exist.
###end p 176
###begin p 177
This work was funded by NIH NIDCD grants DC0018, DC04661, DC05987, and DC07244, by an NRSA fellowship DC006998 (KNO), the American Academy of Otolaryngology Head and Neck Surgery Foundation Resident Research Grant (FS), and V. M. Bloedel Hearing Research Center. Funding institutions had no role in the study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit it for publication.
###end p 177

